Allient (ALNT) Competitors

$60.93 -0.40 (-0.65%)

Closing price 05/18/2026 04:00 PM Eastern

Extended Trading

$62.03 +1.10 (+1.80%)

As of 04:49 AM Eastern

ALNT vs. RAL, MIR, VNT, AEHR, and TXG

Should you buy Allient stock or one of its competitors? MarketBeat compares Allient with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Allient include Ralliant (RAL), Mirion Technologies (MIR), Vontier (VNT), Aehr Test Systems (AEHR), and 10x Genomics (TXG). These companies are all part of the "measuring and control equipment" industry.

How does Allient compare to Ralliant?

Allient (NASDAQ:ALNT) and Ralliant (NYSE:RAL) are both measuring and control equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, media sentiment, valuation, risk, earnings, analyst recommendations and profitability.

61.6% of Allient shares are owned by institutional investors. 15.0% of Allient shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Allient has a net margin of 4.25% compared to Ralliant's net margin of -58.55%. Ralliant's return on equity of 12.49% beat Allient's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Allient	4.25%	12.47%	6.37%
Ralliant	-58.55%	12.49%	6.40%

Allient pays an annual dividend of $0.16 per share and has a dividend yield of 0.3%. Ralliant pays an annual dividend of $0.20 per share and has a dividend yield of 0.3%. Allient pays out 11.2% of its earnings in the form of a dividend. Ralliant pays out -1.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Ralliant is clearly the better dividend stock, given its higher yield and lower payout ratio.

Allient currently has a consensus target price of $72.25, suggesting a potential upside of 18.58%. Ralliant has a consensus target price of $61.90, suggesting a potential upside of 5.12%. Given Allient's higher possible upside, equities research analysts clearly believe Allient is more favorable than Ralliant.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Allient	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Ralliant	1 Sell rating(s)	4 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.50

Allient has higher earnings, but lower revenue than Ralliant. Ralliant is trading at a lower price-to-earnings ratio than Allient, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Allient	$560.59M	1.85	$22.03M	$1.43	42.61
Ralliant	$2.07B	3.19	-$1.22B	-$10.94	N/A

In the previous week, Ralliant had 9 more articles in the media than Allient. MarketBeat recorded 18 mentions for Ralliant and 9 mentions for Allient. Ralliant's average media sentiment score of 0.45 beat Allient's score of -0.04 indicating that Ralliant is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Allient	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Ralliant	3 Very Positive mention(s)	1 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Ralliant beats Allient on 9 of the 16 factors compared between the two stocks.

How does Allient compare to Mirion Technologies?

Allient (NASDAQ:ALNT) and Mirion Technologies (NYSE:MIR) are both measuring and control equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation, media sentiment and analyst recommendations.

Mirion Technologies has higher revenue and earnings than Allient. Allient is trading at a lower price-to-earnings ratio than Mirion Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Allient	$560.59M	1.85	$22.03M	$1.43	42.61
Mirion Technologies	$925.40M	4.87	$28.80M	$0.10	179.87

Allient has a beta of 1.65, suggesting that its stock price is 65% more volatile than the broader market. Comparatively, Mirion Technologies has a beta of 1.07, suggesting that its stock price is 7% more volatile than the broader market.

Allient currently has a consensus price target of $72.25, suggesting a potential upside of 18.58%. Mirion Technologies has a consensus price target of $27.13, suggesting a potential upside of 50.80%. Given Mirion Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Mirion Technologies is more favorable than Allient.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Allient	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Mirion Technologies	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.80

61.6% of Allient shares are owned by institutional investors. Comparatively, 78.5% of Mirion Technologies shares are owned by institutional investors. 15.0% of Allient shares are owned by insiders. Comparatively, 2.2% of Mirion Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Allient has a net margin of 4.25% compared to Mirion Technologies' net margin of 2.56%. Allient's return on equity of 12.47% beat Mirion Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Allient	4.25%	12.47%	6.37%
Mirion Technologies	2.56%	6.44%	3.48%

In the previous week, Allient had 6 more articles in the media than Mirion Technologies. MarketBeat recorded 9 mentions for Allient and 3 mentions for Mirion Technologies. Mirion Technologies' average media sentiment score of 1.03 beat Allient's score of -0.04 indicating that Mirion Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Allient	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Mirion Technologies	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Mirion Technologies beats Allient on 10 of the 17 factors compared between the two stocks.

How does Allient compare to Vontier?

Allient (NASDAQ:ALNT) and Vontier (NYSE:VNT) are both measuring and control equipment companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, profitability, institutional ownership, dividends, analyst recommendations and valuation.

Allient pays an annual dividend of $0.16 per share and has a dividend yield of 0.3%. Vontier pays an annual dividend of $0.10 per share and has a dividend yield of 0.4%. Allient pays out 11.2% of its earnings in the form of a dividend. Vontier pays out 3.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Vontier is clearly the better dividend stock, given its higher yield and lower payout ratio.

Allient has a beta of 1.65, indicating that its share price is 65% more volatile than the broader market. Comparatively, Vontier has a beta of 1.24, indicating that its share price is 24% more volatile than the broader market.

Allient currently has a consensus target price of $72.25, suggesting a potential upside of 18.58%. Vontier has a consensus target price of $42.38, suggesting a potential upside of 51.44%. Given Vontier's higher probable upside, analysts plainly believe Vontier is more favorable than Allient.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Allient	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Vontier	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50

Vontier has higher revenue and earnings than Allient. Vontier is trading at a lower price-to-earnings ratio than Allient, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Allient	$560.59M	1.85	$22.03M	$1.43	42.61
Vontier	$3.08B	1.28	$406.10M	$2.83	9.89

61.6% of Allient shares are held by institutional investors. Comparatively, 95.8% of Vontier shares are held by institutional investors. 15.0% of Allient shares are held by insiders. Comparatively, 1.1% of Vontier shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Vontier has a net margin of 13.37% compared to Allient's net margin of 4.25%. Vontier's return on equity of 37.88% beat Allient's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Allient	4.25%	12.47%	6.37%
Vontier	13.37%	37.88%	10.90%

In the previous week, Allient had 3 more articles in the media than Vontier. MarketBeat recorded 9 mentions for Allient and 6 mentions for Vontier. Vontier's average media sentiment score of 0.08 beat Allient's score of -0.04 indicating that Vontier is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Allient	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Vontier	0 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Vontier beats Allient on 12 of the 17 factors compared between the two stocks.

How does Allient compare to Aehr Test Systems?

Allient (NASDAQ:ALNT) and Aehr Test Systems (NASDAQ:AEHR) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, dividends, risk, earnings, valuation and media sentiment.

Allient currently has a consensus target price of $72.25, indicating a potential upside of 18.58%. Aehr Test Systems has a consensus target price of $68.00, indicating a potential downside of 18.63%. Given Allient's stronger consensus rating and higher probable upside, research analysts clearly believe Allient is more favorable than Aehr Test Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Allient	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Aehr Test Systems	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Allient has a beta of 1.65, meaning that its share price is 65% more volatile than the broader market. Comparatively, Aehr Test Systems has a beta of 3.26, meaning that its share price is 226% more volatile than the broader market.

61.6% of Allient shares are held by institutional investors. Comparatively, 69.7% of Aehr Test Systems shares are held by institutional investors. 15.0% of Allient shares are held by insiders. Comparatively, 6.8% of Aehr Test Systems shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Allient has a net margin of 4.25% compared to Aehr Test Systems' net margin of -25.23%. Allient's return on equity of 12.47% beat Aehr Test Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Allient	4.25%	12.47%	6.37%
Aehr Test Systems	-25.23%	-7.15%	-6.15%

In the previous week, Allient had 1 more articles in the media than Aehr Test Systems. MarketBeat recorded 9 mentions for Allient and 8 mentions for Aehr Test Systems. Aehr Test Systems' average media sentiment score of 0.76 beat Allient's score of -0.04 indicating that Aehr Test Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Allient	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Aehr Test Systems	4 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Allient has higher revenue and earnings than Aehr Test Systems. Aehr Test Systems is trading at a lower price-to-earnings ratio than Allient, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Allient	$560.59M	1.85	$22.03M	$1.43	42.61
Aehr Test Systems	$58.97M	44.57	-$3.91M	-$0.38	N/A

Summary

Allient beats Aehr Test Systems on 11 of the 15 factors compared between the two stocks.

How does Allient compare to 10x Genomics?

Allient (NASDAQ:ALNT) and 10x Genomics (NASDAQ:TXG) are both measuring and control equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, valuation, profitability, risk, dividends, earnings and analyst recommendations.

Allient presently has a consensus target price of $72.25, indicating a potential upside of 18.58%. 10x Genomics has a consensus target price of $23.17, indicating a potential upside of 8.00%. Given Allient's stronger consensus rating and higher probable upside, analysts clearly believe Allient is more favorable than 10x Genomics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Allient	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
10x Genomics	1 Sell rating(s)	9 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.33

Allient has higher earnings, but lower revenue than 10x Genomics. 10x Genomics is trading at a lower price-to-earnings ratio than Allient, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Allient	$560.59M	1.85	$22.03M	$1.43	42.61
10x Genomics	$642.82M	4.24	-$43.54M	-$0.17	N/A

In the previous week, 10x Genomics had 2 more articles in the media than Allient. MarketBeat recorded 11 mentions for 10x Genomics and 9 mentions for Allient. 10x Genomics' average media sentiment score of 0.70 beat Allient's score of -0.04 indicating that 10x Genomics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Allient	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
10x Genomics	3 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Allient has a net margin of 4.25% compared to 10x Genomics' net margin of -3.55%. Allient's return on equity of 12.47% beat 10x Genomics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Allient	4.25%	12.47%	6.37%
10x Genomics	-3.55%	-2.86%	-2.23%

Allient has a beta of 1.65, suggesting that its share price is 65% more volatile than the broader market. Comparatively, 10x Genomics has a beta of 2.05, suggesting that its share price is 105% more volatile than the broader market.

61.6% of Allient shares are owned by institutional investors. Comparatively, 84.7% of 10x Genomics shares are owned by institutional investors. 15.0% of Allient shares are owned by insiders. Comparatively, 8.8% of 10x Genomics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Allient beats 10x Genomics on 9 of the 17 factors compared between the two stocks.

Get Allient News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ALNT vs. The Competition

Export

Metric	Allient	ELEC Industry	Computer Sector	NASDAQ Exchange
Market Cap	$1.04B	$7.26B	$39.06B	$12.29B
Dividend Yield	0.19%	1.64%	3.21%	5.30%
P/E Ratio	42.61	44.67	167.29	25.23
Price / Sales	1.85	3.71	629.66	80.24
Price / Cash	16.67	30.04	47.81	37.30
Price / Book	3.42	4.00	9.63	6.63
Net Income	$22.03M	$188.40M	$1.06B	$335.59M
7 Day Performance	-3.24%	-1.42%	-0.25%	-1.20%
1 Month Performance	-18.10%	2.76%	3.93%	-1.16%
1 Year Performance	91.18%	67.01%	159.82%	28.10%

Allient Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ALNT Allient	4.1636 of 5 stars	$60.93 -0.7%	$72.25 +18.6%	+89.2%	$1.04B	$560.59M	42.61	2,478
RAL Ralliant	1.9771 of 5 stars	$46.43 +1.9%	$50.50 +8.8%	N/A	$5.20B	$2.07B	23.69	7,000	Positive News Earnings Report
MIR Mirion Technologies	3.8743 of 5 stars	$20.14 -0.1%	$27.13 +34.7%	+4.3%	$5.05B	$925.40M	201.40	3,281	Positive News
VNT Vontier	4.4343 of 5 stars	$34.94 +0.4%	$46.50 +33.1%	-24.5%	$4.92B	$3.08B	12.66	7,800
AEHR Aehr Test Systems	2.2946 of 5 stars	$91.19 +6.5%	$68.00 -25.4%	+799.6%	$2.87B	$45.26M	N/A	90	Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ALNT) was last updated on 5/19/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Allient (ALNT) Competitors

ALNT vs. RAL, MIR, VNT, AEHR, and TXG

How does Allient compare to Ralliant?

Summary

How does Allient compare to Mirion Technologies?

Summary

How does Allient compare to Vontier?

Summary

How does Allient compare to Aehr Test Systems?

Summary

How does Allient compare to 10x Genomics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALNT vs. The Competition

Allient Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Allient (ALNT) Competitors

ALNT vs. RAL, MIR, VNT, AEHR, and TXG

How does Allient compare to Ralliant?

Do institutionals & insiders hold more shares of ALNT or RAL?

Is ALNT or RAL more profitable?

Is ALNT or RAL a better dividend stock?

Do analysts rate ALNT or RAL?

Which has stronger earnings & valuation, ALNT or RAL?

Does the media prefer ALNT or RAL?

Summary

How does Allient compare to Mirion Technologies?

Which has stronger earnings & valuation, ALNT or MIR?

Which has more risk & volatility, ALNT or MIR?

Do analysts recommend ALNT or MIR?

Do institutionals & insiders hold more shares of ALNT or MIR?

Is ALNT or MIR more profitable?

Does the media refer more to ALNT or MIR?

Summary

How does Allient compare to Vontier?

Is ALNT or VNT a better dividend stock?

Which has more risk & volatility, ALNT or VNT?

Do analysts recommend ALNT or VNT?

Which has stronger valuation and earnings, ALNT or VNT?

Do institutionals and insiders hold more shares of ALNT or VNT?

Is ALNT or VNT more profitable?

Does the media refer more to ALNT or VNT?

Summary

How does Allient compare to Aehr Test Systems?

Do analysts rate ALNT or AEHR?

Which has more risk and volatility, ALNT or AEHR?

Do institutionals & insiders have more ownership in ALNT or AEHR?

Is ALNT or AEHR more profitable?

Does the media refer more to ALNT or AEHR?

Which has higher earnings and valuation, ALNT or AEHR?

Summary

How does Allient compare to 10x Genomics?

Do analysts recommend ALNT or TXG?

Which has better earnings and valuation, ALNT or TXG?

Does the media refer more to ALNT or TXG?

Is ALNT or TXG more profitable?

Which has more volatility and risk, ALNT or TXG?

Do insiders and institutionals believe in ALNT or TXG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALNT vs. The Competition

Allient Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools